Promising lithium aspartate “dosage” that may prevent and slow Alzheimer’s and Parkinson’s disease

Dr. Tom Guttuso, MD, Professor of Neurology at the University at Buffalo explains the novel results from a recent clinical trial using lithium aspartate in patients with Parkinson’s disease and reviews important details regarding the most promising lithium “dosage”. The Harvard University study cited in the video concluding that Alzheimer’s disease may be caused by lithium deficiency in the brain. Dr. Tom emphasizes that anyone who wishes to take more than 10mg a day of a lithium dietary supplement, like lithium aspartate, should discuss this with their doctor, who will need to monitor blood lithium levels as well as thyroid and kidney function tests long-term. For those who wish to learn more about all of the evidence supporting lithium to potentially prevent and slow Alzheimer's and Parkinson's, Dr. Tom's book, "The Promise of Lithium: How an Over-the-Counter Supplement May Prevent and Slow Alzheimer's and Parkinson's Disease", can be found here: https://www.amazon.com... Dr. Tom is also President and majority owner of e3 Pharmaceuticals (e3) https://www.e3pharmace..., which manufactures an NSF-certified lithium aspartate dietary supplement https://lithitate.com. A primary mission of e3 is to support charity and medical research by devoting 50% of all profits to these endeavors. Disclaimer: The statements made in this video and in the above title and description have not been evaluated by the US Food and Drug Administration (FDA). Dietary supplements, including lithium aspartate, are not intended to diagnose, treat, cure or prevent any disease. Dr. Tom does not personally recommend that anyone take lithium dietary supplements.